Selank Alone: A Focused Tracking Guide for the Anxiolytic Heptapeptide

Selank is a synthetic heptapeptide developed in Russia, modeled on the immunomodulatory peptide tuftsin with a stabilizing tail added. It is most often used for its anxiolytic effect, with a milder cognitive secondary signal. There is an existing Peptide IA post that covers Selank alongside Semax — this one is for people running Selank by itself and want a tighter tracking template.

What it does

Selank appears to modulate GABA and serotonin systems indirectly, with effects on enkephalin metabolism and BDNF expression in animal studies. The subjective experience most users describe is a quieting of background anxiety without the sedation or cognitive dulling of benzodiazepines. It is not euphoric, not a stimulant, and the effect on focus is more a side effect of reduced anxious noise than direct activation.

Typical protocol shape

Selank is almost always used intranasally because oral bioavailability is poor. Protocols tend to be short daily courses — a few weeks at a time — with breaks. Some users run it only on demand for high-stress days. Concentrations vary widely between vendors, so dose-per-spray is the metric that actually matters, not vial concentration in isolation.

What to track daily

• Anxiety score 0-10, ideally morning and evening
• Doses taken and approximate time
• Sleep quality the night before (anxiety and sleep cross-contaminate)
• Caffeine intake — pairing with caffeine changes the felt effect
• Any rebound anxiety in the late afternoon

What to track weekly

• Average anxiety score and trend
• Number of high-anxiety days versus baseline
• Subjective social ease and irritability
• Whether you used any other anxiolytics (alcohol, benzos, kava)
• Adherence

Realistic expectations

Selank's anxiolytic effect is usually described as subtle and accumulative over days, not a single-dose knockout like a benzodiazepine. If you are expecting a dramatic mood shift, you will likely conclude it does nothing. The clinical evidence base is largely Russian-language trials, which are real but small and not replicated widely in Western literature. Treat your own tracked data as the most reliable evidence for your own response.

Common mistakes

• Comparing it to benzodiazepines and dismissing it when the effect is gentler
• Running it continuously for months with no break
• Tracking only mood, not anxiety specifically — they are different signals
• Combining with several other novel peptides at the same time, which makes attribution impossible
• Buying vials without confirming peptide content via a reputable source

A tracking template

A clean Peptide IA setup: a twice-daily anxiety slider, a dose checkbox with timestamp, and a free-text field for context (meetings, conflict, social events). Weekly review: chart the anxiety trend against dose days versus non-dose days. If you cannot see a difference after four weeks, the data is telling you something.

Safety notes

Selank has a clean short-term safety record in the available literature, but long-term human data is sparse. It is not approved by the FDA or EMA. Intranasal use carries the usual mucosal irritation risk. Anyone on prescription anxiolytics or antidepressants should not stack without medical input — interactions are not well characterized.

Peptide IA is an educational and self-tracking tool. Nothing in this post is medical advice. Doses mentioned reflect what is commonly reported in research literature — they are not recommendations. Always consult a qualified physician before starting, changing, or stopping any protocol.